Efficacy and safety of different doses and durations of intravenous immunoglobulin treatment for immune thrombocytopenic purpura

被引：0
|
作者：
Lavon, O. [1 ,2 ]
Noy, R. [1 ]
机构：
[1] Technion, Rappaport Fac Med, Haifa, Israel
[2] Carmel Hosp, Clin Pharmacol & Toxicol, Haifa, Israel
来源：
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 2019年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
EACPT-1058
引用
收藏
页码：S31 / S31
页数：1
相关论文
共 50 条
  • [21] Efficacy of treatment immune thrombocytopenic purpura in pregnancy with corticosteroids and intravenous immunoglobulin: a prospective follow-up of suggested practice
    Wegnelius, Gisela
    Bremme, Katarina
    Lindqvist, Pelle G.
    BLOOD COAGULATION & FIBRINOLYSIS, 2018, 29 (02) : 141 - 147
  • [22] Safety and efficacy of intravenous (IV) anti-D treatment in pregnant women with immune thrombocytopenic purpura (ITP).
    Novoa, MV
    Bussel, JB
    BLOOD, 2001, 98 (11) : 442A - 442A
  • [23] Intravenous immunoglobulin for autoimmune thrombocytopenic purpura
    Bierling, P
    Godeau, B
    HUMAN IMMUNOLOGY, 2005, 66 (04) : 387 - 394
  • [24] Low dose intravenous immunoglobulin for acute immune thrombocytopenic purpura in children
    Nuchprayoon, I
    Seksarn, P
    Vanichsetakul, P
    O-chareon, R
    ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY, 2001, 19 (01): : 11 - 16
  • [25] INTRAVENOUS IMMUNOGLOBULIN OR MEGADOSE METHYLPREDNISOLONE FOR THE TREATMENT OF IDIOPATHIC THROMBOCYTOPENIC PURPURA
    OZSOYLU, S
    AMERICAN JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1991, 13 (03): : 364 - 364
  • [26] Effect of immunoglobulin G (IgG) interchain disulfide bond cleavage on efficacy of intravenous immunoglobulin for immune thrombocytopenic purpura (ITP)
    Machino, Y.
    Ohta, H.
    Suzuki, E.
    Higurashi, S.
    Tezuka, T.
    Nagashima, H.
    Kohroki, J.
    Masuho, Y.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2010, 162 (03): : 415 - 424
  • [27] Alternatives to intravenous immunoglobulins in the treatment of immune thrombocytopenic purpura
    David, M
    Chevalier, I
    VOX SANGUINIS, 2002, 83 : 443 - 445
  • [28] Identification Of Factors That Can Predict a Response To Intravenous Immunoglobulin Treatment In Children With Immune Thrombocytopenic Purpura
    Yoshida, Nao
    Morimoto, Yoshihito
    Kawashima, Nozomu
    Matsumoto, Kimikazu
    Kato, Koji
    BLOOD, 2013, 122 (21)
  • [29] EVALUATION OF INTRAVENOUS AND INTRAMUSCULAR EFFICACY IN CHILDHOOD IMMUNE THROMBOCYTOPENIC PURPURA
    P G Mori
    P Biglino
    E Boeri
    A Calvi
    C Dufour
    A Lavagetto
    A C Molinari
    A Valetto
    N Gabutti
    U Ramenghi
    C Miano
    D De Mattia
    Pediatric Research, 1999, 45 : 939 - 939
  • [30] Aseptic meningitis a sign of efficacy or an adverse effect of intravenous immunoglobulin therapy in severe immune thrombocytopenic purpura?
    Kuhne, T
    Spitz, C
    Imbach, P
    BLOOD, 1996, 88 (10) : 2967 - 2967
12345